文献速递神经MR

多发性硬化中钆基对比剂滞留:一项18年纵向研究的回顾性分析

Retention of Gadolinium-Based Contrast Agents in Multiple Sclerosis: Retrospective Analysis of an 18-Year Longitudinal Study.
PubMed 文献 · AJNR Am J Neuroradiol · 2017-05-11

该回顾性纵向研究纳入23例多次接受钆基对比剂的多发性硬化患者与23名年龄性别匹配的健康对照,评估齿状核和苍白球T1信号强度指数。患者齿状核信号强度指数高于对照(P<.001),且钆基对比剂次数与齿状核(β=0.45,P<.001)及苍白球(β=0.60,P<.001)信号强度指数升高相关;齿状核信号强度指数升高与词语流畅性评分降低相关(β=-0.40,P=.013)。

要点

  • 多发性硬化患者齿状核T1信号强度指数高于未暴露钆基对比剂的健康对照(P<.001)。
  • 钆基对比剂给药次数越多,齿状核(β=0.45)和苍白球(β=0.60)信号强度指数越高。
  • 齿状核信号强度指数升高与词语流畅性评分降低相关(β=-0.40,P=.013)。

核心结论

  • 数据印证既往关于脑组织钆滞留的报道,齿状核和苍白球信号强度指数升高与词语流畅性降低相关,但不能证明因果关系,作者鼓励进一步研究认知与钆基对比剂给药的关系。

研究设计与样本

  • 回顾性纵向队列研究,纳入23例多次接受钆基对比剂的多发性硬化患者和23名年龄、性别匹配的健康对照,评估18年纵向T1加权MR图像上的齿状核和苍白球信号强度指数,参与者接受全面神经心理学测试。

关键影像表现/征象

  • 多发性硬化患者齿状核信号强度指数高于未暴露钆基对比剂的健康对照(P<.001),苍白球信号强度指数与对照无显著差异(P=.19)。

诊断标准与关键数值

  • 信号强度指数在齿状核和苍白球T1加权MR图像上评估;钆基对比剂给药次数与齿状核信号强度指数相关(β=0.45,P<.001),与苍白球信号强度指数相关(β=0.60,P<.001)。
  • 校正年龄、病程和躯体残疾后,齿状核(β=0.43,P=.001)和苍白球(β=0.58,P<.001)的关联保持稳定。
  • 多发性硬化患者齿状核信号强度指数升高与词语流畅性评分降低相关(β=-0.40,P=.013),校正多个疾病严重程度方面后仍显著。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Gadolinium-based contrast agents have been associated with lasting high T1-weighted signal intensity in the dentate nucleus and globus pallidus, with histopathologically confirmed gadolinium retention. We aimed to longitudinally investigate the relationship of multiple gadolinium-based contrast agent administrations to the Signal Intensity Index in the dentate nucleus and globus pallidus and any associations with cognitive function in multiple sclerosis.

MATERIALS AND METHODS: The Signal Intensity Index in the dentate nucleus and globus pallidus was retrospectively evaluated on T1-weighted MR imaging in an 18-year longitudinal cohort study of 23 patients with MS receiving multiple gadolinium-based contrast agent administrations and 23 healthy age- and sex-matched controls. Participants also underwent comprehensive neuropsychological testing.

RESULTS: Patients with MS had a higher Signal Intensity Index in the dentate nucleus (P < .001), but not in the globus pallidus (P = .19), compared with non-gadolinium-based contrast agent-exposed healthy controls by an unpaired t test. Increasing numbers of gadolinium-based contrast agent administrations were associated with an increased Signal Intensity Index in the dentate nucleus (β = 0.45, P < .001) and globus pallidus (β = 0.60, P < .001). This association remained stable with corrections for the age, disease duration, and physical disability for both the dentate nucleus (β = 0.43, P = .001) and globus pallidus (β = 0.58, P < .001). An increased Signal Intensity Index in the dentate nucleus among patients with MS was associated with lower verbal fluency scores, which remained significant after correction for several aspects of disease severity (β = -0.40 P = .013).

CONCLUSIONS: Our data corroborate previous reports of lasting gadolinium retention in brain tissues. An increased Signal Intensity Index in the dentate nucleus and globus pallidus was associated with lower verbal fluency, which does not prove causality but encourages further studies on cognition and gadolinium-based contrast agent administration.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Forslin Y, Shams S, Hashim F, et al. Retention of Gadolinium-Based Contrast Agents in Multiple Sclerosis: Retrospective Analysis of an 18-Year Longitudinal Study. AJNR Am J Neuroradiol. 2017. PMID: 28495943. doi:10.3174/ajnr.A5211

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。